Ultra-Short Course Bedaquiline, Clofazimine, Pyrazinamide and Delamanid Versus Standard Therapy for Drug-Susceptible TB

NCT05556746 · clinicaltrials.gov ↗
PHASE2
Phase
ACTIVE_NOT_RECRUITING
Status
94
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Brigham and Women's Hospital

Collaborators